The relationship between cancer and the immune system is heavily implicated in the outcome of the disease. Unfortunately few methods exist to monitor the immune microenvironment immediately around the tumor. The goal of this project is to develop a novel magnetic resonance imaging (MRI) based reporter gene and apply it to the field of cancer immunology. This will be accomplished by (1) developing a reporter gene based on the HaloTag protein that can report gene expression with contrast on an MR image and (2) proving its applicability to a simple model organism before (3) finally using it to monitor the presence of Interleukin-10 (IL-10) in vicinity of melanoma tumors. Recent work in the Meade lab has produced a suite of Gd(III) contrast agents that bind tightly to the HaloTag protein and dramatically increase MR signal when bound. Combining these technologies creates the potential to construct an MRI based reporter gene system, whereby the expression of a gene produces a bright spot on an MR image. Such a technology would have innumerable uses, particularly in the fields of developmental biology, cancer, and immunology. Each of these fields would benefit greatly from the unparalleled deep tissue resolution offered by MRI. The MR reporter gene system will be tested in Xenopus laevis, a common model organism used in developmental biology, by placing HaloTag under the control of a promoter active in the vasculature. In order to detect IL-10 in situ a cell-based biosensor will be used that includes a modular extracellular sensory architecture to cause specific gene expression upon binding to IL-10. In the proposed system, the binding of IL-10 will result in expression of exogenous, extracellular HaloTag. Exposure to HaloTag targeted contrast agents will result in MR contrast enhancement specifically in locations of elevated IL-10 concentration. This technique is expected to be generalizable to a wide variety of cytokines, eventually allowing detailed descriptions of tumor-immune system interactions on a local level.

Public Health Relevance

One of the major roadblocks to in vivo research is monitoring gene expression in deep tissues. The goal of this project is to address this problem by developing a magnetic resonance based reporter gene system. The ultimate goal is to apply this technology to visualizing tumors based on the components found in their microenvironment.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Predoctoral Individual National Research Service Award (F31)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-F15-P (20))
Program Officer
Korczak, Jeannette F
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northwestern University at Chicago
Schools of Arts and Sciences
United States
Zip Code
Vistain, Luke F; Rotz, Matthew W; Rathore, Richa et al. (2016) Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imaging. Chem Commun (Camb) 52:160-3
Vistain, Luke F; Yamamoto, Natsuho; Rathore, Richa et al. (2015) Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a Co(III) -Ebox Conjugate. Chembiochem 16:2065-72